Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin glargine versus NPH insulin in young children with type 1 diabetes
2009-011231-12Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of insulin glargine in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Sanofi. Primary endpoint: Event rate of all hypoglycemia. Started Jul 2009; status: completed.
02
Drugs
insulin glargine
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2009-011231-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011231-12.